Anticoagulation in Device-Detected Atrial Fibrillation—Uncertainty and Heterogeneity in Value

• by Hanxuan Yu, Jinyi Zhu

• June 8, 2026

Advancing Stroke Care: WashU Medicine Specialists at Barnes-Jewish Hospital Help Chronic Stroke Patients with Innovative Use of Vagus Nerve Stimulation

For years, chronic stroke patients heard familiar feedback regarding their ability to regain strength and mobility after ischemic strokes caused upper-extremity deficits.

• May 6, 2026

• 7 min

Systemic immune-inflammation index predicts post-thrombectomy outcomes and reveals a mediating role in the association between neurocardiac stress and prognosis: a multicenter study

• by Long Yang, Han Zhao, Qingtao Xie, Qitong Chen, Yehong Liu, Hailiang Li, Jun Lu, Bo Du, Jiheng Hao, Jiyou Yu, Chao Sun, Yu Liu, Yujia Zhai, Haibing Liao, Yiming Yin, Hui Chen, Qiuchen Zhao, Yu Feng

• May 29, 2026

Cost-Effectiveness of Anticoagulation Treatment for Subclinical Device-Detected Atrial Fibrillation

• by Aleksi K. Winstén, Ville Langén, K.E. Juhani Airaksinen, Konsta Teppo

• June 8, 2026